Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.
Journal: 1995/September - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 7638175
Abstract:
We have generated herpes simplex virus (HSV) vectors vIE1GT and v alpha 4GT bearing the GLUT-1 isoform of the rat brain glucose transporter (GT) under the control of the human cytomegalovirus ie1 and HSV alpha 4 promoters, respectively. We previously reported that such vectors enhance glucose uptake in hippocampal cultures and the hippocampus. In this study we demonstrate that such vectors can maintain neuronal metabolism and reduce the extent of neuron loss in cultures after a period of hypoglycemia. Microinfusion of GT vectors into the rat hippocampus also reduces kainic acid-induced seizure damage in the CA3 cell field. Furthermore, delivery of the vector even after onset of the seizure is protective, suggesting that HSV-mediated gene transfer for neuroprotection need not be carried out in anticipation of neurologic crises. Using the bicistronic vector v alpha 22 beta gal alpha 4GT, which coexpresses both GT and the Escherichia coli lacZ marker gene, we further demonstrate an inverse correlation between the extent of vector expression in the dentate and the amount of CA3 damage resulting from the simultaneous delivery of kainic acid.
Relations:
Content
Citations
(9)
References
(33)
Diseases
(1)
Conditions
(1)
Chemicals
(3)
Organisms
(5)
Processes
(2)
Anatomy
(3)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 92(16): 7247-7251

Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.

Abstract

We have generated herpes simplex virus (HSV) vectors vIE1GT and v alpha 4GT bearing the GLUT-1 isoform of the rat brain glucose transporter (GT) under the control of the human cytomegalovirus ie1 and HSV alpha 4 promoters, respectively. We previously reported that such vectors enhance glucose uptake in hippocampal cultures and the hippocampus. In this study we demonstrate that such vectors can maintain neuronal metabolism and reduce the extent of neuron loss in cultures after a period of hypoglycemia. Microinfusion of GT vectors into the rat hippocampus also reduces kainic acid-induced seizure damage in the CA3 cell field. Furthermore, delivery of the vector even after onset of the seizure is protective, suggesting that HSV-mediated gene transfer for neuroprotection need not be carried out in anticipation of neurologic crises. Using the bicistronic vector v alpha 22 beta gal alpha 4GT, which coexpresses both GT and the Escherichia coli lacZ marker gene, we further demonstrate an inverse correlation between the extent of vector expression in the dentate and the amount of CA3 damage resulting from the simultaneous delivery of kainic acid.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Geller AI, Breakefield XO. A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science. 1988 Sep 23;241(4873):1667–1669.[PMC free article] [PubMed] [Google Scholar]
  • Battleman DS, Geller AI, Chao MV. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci. 1993 Mar;13(3):941–951.[PMC free article] [PubMed] [Google Scholar]
  • Bergold PJ, Casaccia-Bonnefil P, Zeng XL, Federoff HJ. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6165–6169.[PMC free article] [PubMed] [Google Scholar]
  • Geller AI, During MJ, Haycock JW, Freese A, Neve R. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7603–7607.[PMC free article] [PubMed] [Google Scholar]
  • Auer RN, Siesjö BK. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol. 1988 Dec;24(6):699–707. [PubMed] [Google Scholar]
  • Beal MF, Swartz KJ, Finn SF, Mazurek MF, Kowall NW. Neurochemical characterization of excitotoxin lesions in the cerebral cortex. J Neurosci. 1991 Jan;11(1):147–158.[PMC free article] [PubMed] [Google Scholar]
  • Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3655–3659.[PMC free article] [PubMed] [Google Scholar]
  • DeLuca NA, McCarthy AM, Schaffer PA. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol. 1985 Nov;56(2):558–570.[PMC free article] [PubMed] [Google Scholar]
  • Shih MF, Arsenakis M, Tiollais P, Roizman B. Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5867–5870.[PMC free article] [PubMed] [Google Scholar]
  • Ho DY, Mocarski ES. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology. 1988 Nov;167(1):279–283. [PubMed] [Google Scholar]
  • Ho DY. Amplicon-based herpes simplex virus vectors. Methods Cell Biol. 1994;43(Pt A):191–210. [PubMed] [Google Scholar]
  • McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG, Pitchford S. The cytosensor microphysiometer: biological applications of silicon technology. Science. 1992 Sep 25;257(5078):1906–1912. [PubMed] [Google Scholar]
  • Raley-Susman KM, Miller KR, Owicki JC, Sapolsky RM. Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology. J Neurosci. 1992 Mar;12(3):773–780.[PMC free article] [PubMed] [Google Scholar]
  • Sapolsky RM. Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci. 1986 Aug;6(8):2240–2244.[PMC free article] [PubMed] [Google Scholar]
  • Sapolsky RM, Stein BA. Status epilepticus-induced hippocampal damage is modulated by glucose availability. Neurosci Lett. 1989 Feb 13;97(1-2):157–162. [PubMed] [Google Scholar]
  • Ho DY, Fink SL, Lawrence MS, Meier TJ, Saydam TC, Dash R, Sapolsky RM. Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J Neurosci Methods. 1995 Apr;57(2):205–215. [PubMed] [Google Scholar]
  • Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985 Feb;14(2):375–403. [PubMed] [Google Scholar]
  • Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 1988 Jun 7;451(1-2):205–212. [PubMed] [Google Scholar]
  • Zeevalk GD, Nicklas WJ. Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem. 1992 Oct;59(4):1211–1220. [PubMed] [Google Scholar]
  • Blennow G, Nilsson B, Siesjö BK. Influence of reduced oxygen availability on cerebral metabolic changes during bicuculline-induced seizures in rats. J Cereb Blood Flow Metab. 1985 Sep;5(3):439–445. [PubMed] [Google Scholar]
  • Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. Adv Neurol. 1983;34:261–275. [PubMed] [Google Scholar]
  • Lee WH, Bondy CA. Ischemic injury induces brain glucose transporter gene expression. Endocrinology. 1993 Dec;133(6):2540–2544. [PubMed] [Google Scholar]
  • Washko P, Levine M. Inhibition of ascorbic acid transport in human neutrophils by glucose. J Biol Chem. 1992 Nov 25;267(33):23568–23574. [PubMed] [Google Scholar]
  • Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 1993 Oct 29;262(5134):689–695. [PubMed] [Google Scholar]
  • Claiborne BJ, Amaral DG, Cowan WM. A light and electron microscopic analysis of the mossy fibers of the rat dentate gyrus. J Comp Neurol. 1986 Apr 22;246(4):435–458. [PubMed] [Google Scholar]
  • Nadler JV, Cuthbertson GJ. Kainic acid neurotoxicity toward hippocampal formation: dependence on specific excitatory pathways. Brain Res. 1980 Aug 11;195(1):47–56. [PubMed] [Google Scholar]
  • Coyle JT. Neurotoxic action of kainic acid. J Neurochem. 1983 Jul;41(1):1–11. [PubMed] [Google Scholar]
  • Ferkany JW, Coyle JT. Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J Pharmacol Exp Ther. 1983 May;225(2):399–406. [PubMed] [Google Scholar]
  • Pastuszko A, Wilson DF, Erecińska M. Effects of kainic acid in rat brain synaptosomes: the involvement of calcium. J Neurochem. 1984 Sep;43(3):747–754. [PubMed] [Google Scholar]
  • Krespan B, Berl S, Nicklas WJ. Alteration in neuronal-glial metabolism of glutamate by the neurotoxin kainic acid. J Neurochem. 1982 Feb;38(2):509–518. [PubMed] [Google Scholar]
  • Pocock JM, Murphie HM, Nicholls DG. Kainic acid inhibits the synaptosomal plasma membrane glutamate carrier and allows glutamate leakage from the cytoplasm but does not affect glutamate exocytosis. J Neurochem. 1988 Mar;50(3):745–751. [PubMed] [Google Scholar]
  • Kauppinen RA, Enkvist K, Holopainen I, Akerman KE. Glucose deprivation depolarizes plasma membrane of cultured astrocytes and collapses transmembrane potassium and glutamate gradients. Neuroscience. 1988 Jul;26(1):283–289. [PubMed] [Google Scholar]
  • Levy DI, Lipton SA. Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology. 1990 May;40(5):852–855. [PubMed] [Google Scholar]
Department of Biological Sciences, Stanford University, CA 94305, USA.
Department of Biological Sciences, Stanford University, CA 94305, USA.
Abstract
We have generated herpes simplex virus (HSV) vectors vIE1GT and v alpha 4GT bearing the GLUT-1 isoform of the rat brain glucose transporter (GT) under the control of the human cytomegalovirus ie1 and HSV alpha 4 promoters, respectively. We previously reported that such vectors enhance glucose uptake in hippocampal cultures and the hippocampus. In this study we demonstrate that such vectors can maintain neuronal metabolism and reduce the extent of neuron loss in cultures after a period of hypoglycemia. Microinfusion of GT vectors into the rat hippocampus also reduces kainic acid-induced seizure damage in the CA3 cell field. Furthermore, delivery of the vector even after onset of the seizure is protective, suggesting that HSV-mediated gene transfer for neuroprotection need not be carried out in anticipation of neurologic crises. Using the bicistronic vector v alpha 22 beta gal alpha 4GT, which coexpresses both GT and the Escherichia coli lacZ marker gene, we further demonstrate an inverse correlation between the extent of vector expression in the dentate and the amount of CA3 damage resulting from the simultaneous delivery of kainic acid.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.